The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Incyte regarding the New Drug Application (NDA) for ruxolitinib extended-release (XR) tablets for once-daily ...

Anyone who has been prescribed these tablets are asked to stop taking them and contact Bryant Ranch at [email protected] or 877-885-0882.

The recalled lots include Morphine Sulfate 30mg Extended-Release tablets; NDC 63629-1088-01; Lot #17642; Expiration Date 11/30/2023, and Morphine Sulfate 60mg Extended-Release tablets; ...

It comes as an extended-release oral tablet and extended-release oral capsule. Extended-release tablets and capsules release the medication slowly over time as they pass through your digestive system.

Release Summary. Santarus (NASDAQ: SNTS) announced the U.S. commercial launch of UCERIS™ (budesonide) once daily tablets for the induction of remission in patients with active, mild to moderate ...

Weston, Florida, Apotex Corp is voluntarily recalling three (3) lots of Guanfacine Extended-Release Tablets 2mg to the consumer level due to trace amounts of Quetiapine Fumarate in one lot RX1663.

FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents First once-daily nonstimulant to be ...

Sandoz Inc. (“Sandoz”) is initiating a voluntary recall of 13 lots (listed below) of oral Orphenadrine Citrate 100 mg Extended Release (ER) Tablets to the consumer level.

Table II: Extended-release model formulation containing propranolol hydrochloride as the active ingredient. Tablet preparation procedure. Propranolol HCl, hypromellose, and microcrystalline cellulose ...

Orphenadrine Citrate 100 mg Extended Release tablets that went to customers from August 2019 through April 2021. The 1,000-count bottle lot is No. KS3939, expiration 03/2023.

REDWOOD CITY, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the ...

WESTON, Fla., March 31, 2021 /CNW/ - Apotex Corp is voluntarily recalling three (3) lots of Guanfacine Extended-Release Tablets 2mg to the consumer level due to trace amounts of Quetiapine ...